Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jun 17, 2024
Document Date
Jun 13, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
Goff Brian